B96.1 Klebsiella pneumoniae [K. pneumoniae] as the cause of diseases classified elsewhere

Name of the Condition

• Klebsiella pneumoniae [K. pneumoniae] as the cause of diseases classified elsewhere

Summary

This code is used to identify conditions where Klebsiella pneumoniae is identified as the underlying cause of a disease that is classified elsewhere in the ICD-10-CM classification system. The bacteria are not the primary focus of the disease but contribute to its development or exacerbation. This code is applied when the specific bacterial agent is known but the primary disease is categorized under a different code.

Causes

The causes are attributed to Klebsiella pneumoniae, a gram-negative bacterium that can act as an opportunistic pathogen. It may cause infections by colonizing the respiratory or gastrointestinal tract and then spreading to other sites, particularly in individuals with compromised immunity or underlying conditions.

Risk Factors

• Underlying chronic conditions that weaken the immune system, such as diabetes or chronic lung disease.
• Recent antibiotic use, which may disrupt normal flora and allow bacterial overgrowth.
• Invasive medical procedures that introduce bacteria into sterile areas.
• Prolonged hospitalization, increasing exposure to healthcare-associated bacteria.
• Age extremes (very young or elderly), where immune function is typically reduced.

Symptoms

Symptoms vary depending on the primary disease being classified elsewhere. For example, in respiratory infections, symptoms may include fever, cough, and sputum production. In bloodstream infections, signs of sepsis such as fever, chills, and hypotension may occur.

Diagnosis

Diagnosis requires identification of Klebsiella pneumoniae through clinical or laboratory findings. This may involve culturing specimens from the affected site (e.g., sputum, blood, or urine) and confirming the bacterial species. Antibiotic susceptibility testing is often performed to guide treatment.

Treatment Options

Treatment typically involves antibiotics targeted against Klebsiella pneumoniae, such as cephalosporins, carbapenems, or fluoroquinolones. The choice of antibiotic depends on susceptibility patterns and the severity of the infection. Supportive care, such as fluid management or oxygen therapy, may also be necessary.

Prognosis and Follow-Up

Prognosis depends on the underlying disease, the patient’s overall health, and the timeliness of treatment. Early identification and appropriate antibiotic therapy improve outcomes. Follow-up may include monitoring for resolution of infection and managing any complications related to the primary disease.

Complications

Complications can include sepsis, respiratory failure, or the spread of infection to other organs. Infections caused by multidrug-resistant strains of Klebsiella pneumoniae may be more difficult to treat and associated with higher morbidity.

Lifestyle & Prevention

• Practice good hand hygiene to reduce the risk of bacterial transmission.
• Avoid unnecessary antibiotic use to prevent resistance.
• Manage underlying health conditions to support immune function.
• Follow healthcare facility protocols for infection control, especially in hospital settings.

When to Seek Professional Help

Seek medical attention if symptoms of infection worsen or if there are signs of sepsis, such as high fever, confusion, or difficulty breathing. Prompt evaluation is important for appropriate treatment.

Tips for Medical Coders

When assigning this code, ensure that Klebsiella pneumoniae is documented as the cause of a disease classified elsewhere. The primary disease should be coded separately, and this code should be added as a secondary code to indicate the bacterial agent. Verify that laboratory or clinical documentation supports the identification of the bacteria.